Regular IssueDevicesAccelerometer-based atrioventricular synchronous pacing with a ventricular leadless pacemaker: Results from the Micra atrioventricular feasibility studies
Keywords
Cited by (0)
The MASS, MASS2, and MARVEL studies were funded by Medtronic, plc (ClinicalTrials.gov numbers: NCT02930980, NCT03157297). LAC: Compensation for Services: Abbott, Biosense Webster, Pfizer, Biotronik, Medtronic; Fellowship Support: Biotronik, Boston Scientific, Medtronic. PR: Compensation for Services: Medtronic. SKK: Speaker's Bureau: Bayer/Schering Pharma, Boston Scientific, Medtronic, Pfizer. SI: None. CG: Compensation for Services: Medtronic. MGB: None. PN: Research Grants: Biosense Webster, Abbott, EBR Systems, Medtronic, Boston Scientific, CardioFocus, Inc, VytronUS, Inc, EpiEP. JBB: Compensation for Services: Cook Medical, Inc; Speaker's Bureau: Medtronic, Merit Medical Systems. LM: Compensation for Services: Abbott, Boston Scientific, Medtronic; Fellowship Support: Abbott, Boston Scientific, Medtronic. EHG: None. VSS: None. GZD: Compensation for Services: Medtronic; Speaker's Bureau: Bayer/Schering Pharma, Biotronik, Abbott, Medtronic, Pfizer. NC: Compensation for Services: Medtronic. TJS, VS, KS, NMW: Employment and Shareholder: Medtronic. CS: Compensation for Services: Biotronik, Medtronic; Speaker's Bureau: Abbott, Biotronik, Boston Scientific, Medtronic.